Compare SGMT & NAKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SGMT | NAKA |
|---|---|---|
| Founded | 2006 | 2019 |
| Country | United States | United States |
| Employees | N/A | 61 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.4M | 188.2M |
| IPO Year | 2021 | N/A |
| Metric | SGMT | NAKA |
|---|---|---|
| Price | $4.73 | $0.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $26.38 | $4.25 |
| AVG Volume (30 Days) | 296.4K | ★ 4.2M |
| Earning Date | 03-11-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,517.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.73 | $0.23 |
| 52 Week High | $11.41 | $29.50 |
| Indicator | SGMT | NAKA |
|---|---|---|
| Relative Strength Index (RSI) | 36.22 | 46.13 |
| Support Level | N/A | $0.25 |
| Resistance Level | $6.62 | $0.29 |
| Average True Range (ATR) | 0.24 | 0.02 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 7.75 | 36.44 |
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
Nakamoto Inc is a Bitcoin company building a world-wide portfolio of Bitcoin-native companies to provide commercial and financial infrastructure for the next generation of capital markets.